Total Funding
48
4
Total FundingVenture - Series Unknown raised
Growth Score 48 in past quarter
-5 pts
Heat Score 4 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
38263
Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.
- Aaron Koenig: Chief Medical OfficerPast Role: Delix Therapeutics, Chief Medical Officer
- John Donello: CSO
About the Company
Syndeio Biosciences is a clinical-stage biotechnology company focused on developing therapies to restore and enhance synaptic health in central nervous system (CNS) disorders.